BSYI (Biosyntech) Cyclically Adjusted PB Ratio: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosyntech Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biosyntech  (OTCPK:BSYI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biosyntech Cyclically Adjusted PB Ratio Related Terms


Biosyntech Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Biosyntech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Cyclically Adjusted PB Ratio Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSYI vs NSPX, HSTC, PZRXQ: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Biosyntech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biosyntech's Cyclically Adjusted PB Ratio falls into.



Biosyntech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biosyntech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2009 is calculated as:

For example, Biosyntech's adjusted Book Value per Share data for the three months ended in Dec. 2009 was:

Adj_Book=Book Value per Share/CPI of Dec. 2009 (Change)*Current CPI (Dec. 2009)
=-0.112/90.7032*90.7032
=-0.112

Current CPI (Dec. 2009) = 90.7032.

Biosyntech Quarterly Data

Book Value per Share CPI Adj_Book
200003 0.175 74.901 0.212
200006 0.268 75.454 0.322
200009 0.243 75.928 0.290
200012 0.200 76.402 0.237
200103 0.166 76.719 0.196
200106 0.136 77.983 0.158
200109 0.113 77.904 0.132
200112 0.097 76.956 0.114
200203 0.079 78.141 0.092
200206 0.067 78.931 0.077
200209 0.046 79.721 0.052
200212 0.024 79.879 0.027
200303 0.008 81.459 0.009
200306 -0.009 80.985 -0.010
200309 -0.001 81.459 -0.001
200312 -0.020 81.538 -0.022
200403 0.046 82.091 0.051
200406 0.038 83.039 0.042
200409 0.015 82.960 0.016
200412 -0.010 83.276 -0.011
200503 -0.040 83.987 -0.043
200506 -0.068 84.461 -0.073
200509 0.029 85.647 0.031
200512 -0.001 85.015 -0.001
200603 0.078 85.805 0.082
200606 0.164 86.516 0.172
200609 0.146 86.279 0.153
200612 0.122 86.437 0.128
200703 0.100 87.780 0.103
200706 0.089 88.412 0.091
200709 0.071 88.412 0.073
200712 0.048 88.491 0.049
200803 0.017 88.965 0.017
200806 0.000 91.177 0.000
200809 0.007 91.414 0.007
200812 -0.031 89.518 -0.031
200903 -0.050 90.071 -0.050
200906 -0.070 90.940 -0.070
200909 -0.107 90.624 -0.107
200912 -0.112 90.703 -0.112

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.